| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.26 | 0.03 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |